Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on Teladoc (TDOC – Research Report). The company’s ...

CENTRAL TRUST Co decreased its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 11.0% during the 4th ...

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Garty, chief technology officer, clinical data, provided his key takeaways from a panel he participated in on the growing interest ...

With Veeva RIM, Servier has a solution that enables quick adaptation to evolving EU regulatory demands. Veeva is partnering ...

Pharmaceutical software company Veeva Systems has sued Microsoft in California federal court, alleging Microsoft's Viva ...

Leading biopharma to unify global regulatory operations on a single platform to speed submissions for new patient therapies BARCELONA, Spain, Feb. 4, 2025 /PRNewswire/ -- Veeva Systems ...

BARCELONA, Spain, Feb. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Servier will adopt Veeva RIM to unify its global regulatory operations. By bringing regulatory processes ...

Hantz Financial Services Inc. lessened its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 64.8% during the 4th ...

Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $7,775.33 today based on a price of $233.26 for VEEV at the time of writing.